ABBOTT LABORATORIES (NASDAQ:ABT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

As previously reported, Abbott has Agreements Regarding Change in Control (“Agreements”) with its named executive officers, other than Miles D. White, Abbott’s Chairman of the Board and Chief Executive Officer, who is not party to an Agreement Regarding Change in Control.

The Agreements provide that if Abbott gives notification of extension before the Expiration Date (December 31, 2016), the Agreement’s term shall continue through the second anniversary of the Expiration Date.

On November 16, 2016, Abbott notified the named executive officers who are party to the Agreements that the term of the Agreements was extended through December 31, 2018.